Magnus Daniel Hansson

Magnus Daniel Hansson is a researcher affiliated with the Department of Laboratory Medicine at Karolinska Institutet in Stockholm, Sweden. His work focuses on clinical chemistry with particular emphasis on kidney function assessment, biomarker discovery, and neurological disorders. His research spans multiple disciplines including nephrology, neurology, and clinical laboratory medicine.

Dr. Hansson earned his University Medical Degree from Karolinska Institutet in 2000, followed by a Licentiate Degree in 2004, and completed his Doctor of Philosophy in 2007 with a thesis titled "Studies on human sterol 27-hydroxylase with emphasis on its mechanism of regulation and metabolic consequences of a deficient enzyme." His formal education established a foundation in medical biochemistry that informs his current research.

His research interests primarily center around the accurate measurement of kidney function through glomerular filtration rate (GFR) estimation, with numerous publications on creatinine- and cystatin C-based equations. He has made significant contributions to extending GFR equations across different age groups, from children to adults, and has explored the impact of race and sex on kidney function assessment. His work also extends to neurological conditions, particularly Multiple Sclerosis, Guillain-Barre syndrome, and cerebrospinal fluid biomarker analysis. Dr. Hansson has been instrumental in the European Kidney Function Consortium, validating and improving methods for kidney function assessment across diverse populations.

Analysis of Dr. Hansson's recent publications reveals a strong focus on refining methods for estimating glomerular filtration rate, with particular attention to the integration of cystatin C measurements and the development of more accurate, race- and sex-neutral equations. His work bridges clinical chemistry, nephrology, and neurology, demonstrating how biomarker research can improve diagnostic accuracy across multiple medical specialties. Recent trends show increasing application of machine learning approaches to validate and improve GFR estimation models, with significant implications for clinical practice guidelines.

Dr. Hansson collaborates extensively with researchers across Europe and internationally, as evidenced by his numerous multi-center studies. His work has implications for clinical practice guidelines regarding kidney function assessment and has been published in high-impact journals including the New England Journal of Medicine. His research on cerebrospinal fluid biomarkers has advanced diagnostic approaches for neurological conditions, while his work on kidney function assessment has direct clinical applications for medication dosing and disease management.